Hospital-Acquired Infection (HAI) Control Market

Hospital-Acquired Infection (HAI) Control Market Size, Market Forecast and Outlook By FMI

Summary of the Hospital-Acquired Infection (HAI) Control Market

• Demand and Growth Drivers
  • Regulatory mandates for infection surveillance and prevention programs are creating compliance-driven procurement of hand hygiene products, surface disinfectants, sterilization equipment, and personal protective equipment across hospital systems.
  • The clinical and financial burden of HAIs, including surgical site infections, catheter-related bloodstream infections, and ventilator-associated pneumonia, is driving hospital investment in infection prevention infrastructure.
  • Sterilization and disinfection technology upgrades, including UV-C disinfection and hydrogen peroxide vapor systems, are creating capital equipment procurement cycles in hospital infection control departments.
• Product and Segment View
  • Consumables is expected to hold 46.9% of the Component segment in 2026.
  • Hand Hygiene Management is expected to hold 38.6% of the Infection Control Practice segment in 2026.
  • Sterilization Technology is expected to hold 41.2% of the Technology segment in 2026.
• Geography and Competitive Outlook
  • USA is expected to lead growth at 6.9%, supported by the largest hospital system and HAI regulatory framework.
  • South Korea follows at 6.9%, driven by healthcare quality accreditation programs and hospital investment.
  • Olympus Corporation and established players compete on product portfolio and compliance expertise.
• Analyst Opinion
  • The Hospital-Acquired Infection (HAI) Control Market is evolving as new technologies and treatment approaches expand beyond established product categories.
  • Regulatory developments and reimbursement frameworks are shaping adoption patterns and competitive dynamics across key markets.
  • Companies that combine product portfolio with compliance expertise are expected to gain procurement share over the forecast period.
  • Emerging technologies and pipeline developments are creating opportunities for both established players and new market entrants.

Key Takeaways

• The Hospital-Acquired Infection (HAI) Control Market was valued at USD 7.44 billion in 2025.
• By 2036, the Hospital-Acquired Infection (HAI) Control Market is expected to be worth USD 15.34 billion.
• From 2026 to 2036, the market is projected to expand at a CAGR of 6.8%.
• The market is projected to create an incremental opportunity of USD 7.40 billion between 2026 and 2036.
• In 2026, Consumables is expected to account for 46.9% of the Component segment, driven by regulatory mandates for infection prevention and the clinical burden of surgical site, bloodstream, and urinary tract infections in hospital settings.
• USA (6.9%) and South Korea (6.9%) are two of the fastest growing markets in the world.

Hospital-Acquired Infection (HAI) Control Market Definition

The Hospital-Acquired Infection (HAI) Control Market covers consumables, equipment, and services for infection prevention in healthcare settings, including hand hygiene products, surface disinfectants, sterilization systems, PPE, environmental monitoring, and infection control consulting and training services.

Hospital-Acquired Infection (HAI) Control Market Inclusions

Market scope covers all commercially available products and services categorized by component (Component, Consumables, Equipment, Services), infection control practice (Infection Control Practice, Hand Hygiene Management, Surface Disinfection, Instrument Sterilization, Personal Protective Equipment Usage, Environmental Monitoring), technology (Technology, Sterilization Technology, Disinfection Technology), application (Application, Surgical Site Infections, Bloodstream Infections, Urinary Tract Infections, Hospital Acquired Pneumonia, Gastrointestinal Infections), end-user (End-user, Hospitals and Intensive Care Units, Ambulatory Surgical and Diagnostic Centers, Other End Users), distribution channel (Distribution Channel, Direct Sales to Healthcare Facilities, Distributor Sales). Revenue coverage spans the 2026 to 2036 forecast period.

Hospital-Acquired Infection (HAI) Control Market Exclusions

Pharmaceutical medications, equipment used in diagnostic microbiology labs, and basic hospital cleaning services that aren't specifically categorized as infection prevention items are not included in the scope.

Hospital-Acquired Infection (HAI) Control Market Research Methodology

• Primary Research: FMI analysts interviewed key market procurement decision-makers and industry stakeholders.
• Desk research: Integrated information from manufacturer disclosures, clinical and trade databases, industry periodicals, and regulatory filings.
• Market sizing and forecasting: Adoption velocity modeling, cross-validation against industry benchmarks, and bottom-up aggregation across sectors and geographies.
• Data validation: Quarterly cross-checked with manufacturer disclosures, industry production data, and regulatory databases

Why is the Hospital-Acquired Infection (HAI) Control Market Growing?

• 46.9% of the component sector is made up of consumables, which reflects the regular purchases of PPE, sterilization supplies, waste disposal items, and disinfectants made by hospital infection control programs.
• Due to clinical data that links hand hygiene adherence to HAI reduction and regulatory compliance requirements, hand hygiene management accounts for 38.6% of the infection control practice segment.
• The largest hospital system and the HAI regulatory framework underpin the USA's 6.9% growth rate.

The Hospital-Acquired Infection (HAI) Control Market is growing as healthcare systems invest in infection prevention infrastructure. Consumables hold 46.9% of the component segment, with equipment and services contributing the capital and advisory components. Hand hygiene management leads at 38.6%, with surface disinfection, instrument sterilization, PPE usage, and environmental monitoring serving complementary prevention practices.

Sterilization technology accounts for 41.2% of the technology segment, with chemical, UV, and hydrogen peroxide disinfection technologies providing the disinfection layer. Surgical site infections represent 34.5% of the application segment, with bloodstream infections, urinary tract infections, hospital-acquired pneumonia, and GI infections contributing additional clinical demand.

Hospitals and ICUs hold 58.7% of end-user demand, with ambulatory surgical centers and long-term care facilities contributing the balance. Direct sales to healthcare facilities represent 48.5% of distribution, with long-term supply contracts and group purchasing organizations serving as primary procurement channels.

Market Segmentation Analysis

• Consumables holds 46.9% of the Component segment in 2026.
• Hand Hygiene Management accounts for 38.6% of the Infection Control Practice segment.

The Hospital-Acquired Infection (HAI) Control Market is organized across 6 segmentation dimensions: Component, Infection Control Practice, Technology, Application, End-user, Distribution Channel.

Insights into the Consumables Component Segment

In 2026, Consumables is expected to account for 46.9% of the Component segment. Key sub-categories include Disinfectants, Sterilization Consumables, Waste Disposal Products.

Consumables hold 46.9% of the segment, contributing to segment diversity.

Insights into the Sterilization Technology Segment

In 2026, Sterilization Technology is expected to account for 41.2% of the Technology segment. Key sub-categories include Heat Sterilization, Low Temperature Sterilization.

Sterilization Technology holds 41.2% of the segment, contributing to segment diversity.

Hospital-Acquired Infection (HAI) Control Market Drivers, Restraints, and Opportunities

• Healthcare regulations mandate that accredited hospitals implement infection surveillance procedures, monitor hand hygiene compliance, and validate sterilization.
• About 1 in 31 hospital patients in the US suffer from HAIs, which result in high treatment expenses and prolonged hospital stays.
• Hospitals are using capital equipment upgrades such as UV-C automatic disinfection robots, hydrogen peroxide vapor systems, and antimicrobial surface coatings to augment human cleaning procedures.

Clinical demand, technological advancements, legal frameworks, and access dynamics all influence the hospital-acquired infection (HAI) control market. Growth is a reflection of how adoption barriers and demand drivers are balanced.

Regulatory Compliance and Surveillance Mandates

Healthcare regulators require infection surveillance programs, hand hygiene compliance monitoring, and sterilization validation in accredited hospitals. These mandates create baseline procurement demand for consumables, monitoring systems, and compliance reporting tools that is less sensitive to discretionary budgets.

Clinical and Financial Burden of HAIs

HAIs affect approximately 1 in 31 hospital patients in the US, generating significant treatment costs and extended hospital stays. The financial penalties associated with elevated HAI rates under pay-for-performance reimbursement models create economic incentives for infection prevention investment.

Technology Upgrades in Disinfection

UV-C automated disinfection robots, hydrogen peroxide vapor systems, and antimicrobial surface coatings represent capital equipment upgrades that hospitals are adopting to supplement manual cleaning protocols. These technologies offer measurable environmental bioburden reduction.

Antimicrobial Resistance and Emerging Pathogens

Growing antimicrobial resistance and the emergence of drug-resistant organisms like C. difficile and MRSA are increasing the clinical urgency of infection prevention. Enhanced environmental disinfection and antibiotic stewardship programs are driving procurement across hospital systems.

Analysis of Hospital-Acquired Infection (HAI) Control Market By Key Countries

• USA at 6.9% is supported by the largest hospital system and HAI regulatory framework.
• South Korea at 6.9% is supported by healthcare quality accreditation programs and hospital investment.
• Japan at 6.8% is supported by advanced hospital hygiene infrastructure and high compliance standards.
• EU at 6.8% is supported by harmonized healthcare quality standards and infection control regulations.

The global Hospital-Acquired Infection (HAI) Control Market is projected to expand at a CAGR of 6.8% from 2026 to 2036. The analysis covers more than 30 countries.

Demand Outlook for Hospital-Acquired Infection (HAI) Control Market in the United States

The United States is projected to grow at 6.9% through 2036. The largest hospital system and HAI regulatory framework are the primary factors shaping demand.

• The largest hospital system and HAI regulatory framework supports demand growth.
• Expanding demand base contributes to market expansion.
• Regulatory and institutional frameworks support market development.

Future Outlook for Hospital-Acquired Infection (HAI) Control Market in the United Kingdom

The United Kingdom is projected to grow at 6.7% through 2036. NHS infection prevention mandates and surveillance programs are the primary factors shaping demand.

• NHS infection prevention mandates and surveillance programs supports demand growth.
• Expanding demand base contributes to market expansion.
• Regulatory and institutional frameworks support market development.

Opportunity Analysis of Hospital-Acquired Infection (HAI) Control Market in Japan

Japan is projected to grow at 6.8% through 2036. Advanced hospital hygiene infrastructure and high compliance standards are the primary factors shaping demand.

• Advanced hospital hygiene infrastructure and high compliance standards supports demand growth.
• Expanding demand base contributes to market expansion.
• Regulatory and institutional frameworks support market development.

In-depth Analysis of Hospital-Acquired Infection (HAI) Control Market in the European Union

The European Union is projected to grow at 6.8% through 2036. Harmonized healthcare quality standards and infection control regulations are the primary factors shaping demand.

• Harmonized healthcare quality standards and infection control regulations supports demand growth.
• Expanding demand base contributes to market expansion.
• Regulatory and institutional frameworks support market development.

Sales Analysis of Hospital-Acquired Infection (HAI) Control Market in South Korea

South Korea is projected to grow at 6.9% through 2036. Healthcare quality accreditation programs and hospital investment are the primary factors shaping demand.

• Healthcare quality accreditation programs and hospital investment supports demand growth.
• Expanding demand base contributes to market expansion.
• Regulatory and institutional frameworks support market development.

Competitive Landscape and Strategic Positioning

• Based on its product line and compliance knowledge, Olympus Corporation is in the forefront.
• Well-established competitors compete based on their service network, geographic reach, product portfolio, and compliance knowledge.
• New competitors are concentrating on narrow market positioning and specialized skills.

Olympus Corporation's product line and compliance knowledge give it a dominant position. BD uses complimentary skills to keep its strong position.3M, Xenex Disinfection Services Inc., and Getinge AB compete based on their geographic reach and specific skills. These businesses use tailored strategies to cater to specific market segments.Investments in distribution infrastructure, regulatory compliance, and product portfolio are necessary for market entry. Customer relationships and track records are advantageous to established businesses.

Key Companies in the Hospital-Acquired Infection (HAI) Control Market

Key global companies leading the Hospital-Acquired Infection (HAI) Control Market include:

• Olympus Corporation, BD, Getinge AB, Xenex Disinfection Services Inc. are the established market leaders with broad capabilities across product portfolio and compliance expertise.
• 3M, Steris Corporation, Ecolab Inc. has built regional positions through specialized capabilities.
• Cantel Medical Corp. (Sotera Health), Other HAI Control Providers (combined) are entering through niche specialization and technology-driven differentiation.

Competitive Benchmarking: Hospital-Acquired Infection (HAI) Control Market

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Hospital-Acquired Infection (HAI) Control Market

• In 2025, Olympus Corporation expanded its product portfolio capabilities across key markets.
• In 2025, BD launched the BD Surgiphor™ Surgical Wound Irrigation System in Europe to help reduce surgical site infections by lowering bacterial load.

Key Players in the Hospital-Acquired Infection (HAI) Control Market:

Major Global Players:

• Olympus Corporation
• BD
• Getinge AB
• Xenex Disinfection Services Inc.
• 3M
• Steris Corporation
• Ecolab Inc.

Emerging Players/Startups

• Cantel Medical Corp. (Sotera Health)
• Other HAI Control Providers (combined)

Report Scope and Coverage

Market Segmentation Analysis

Hospital-Acquired Infection (HAI) Control Market Market Segmented by Component:

• Consumables
  • Disinfectants
  • Sterilization Consumables
  • Waste Disposal Products
  • Personal Protective Equipment
• Equipment
  • Sterilization Equipment
  • Disinfection Equipment
• Services
  • Infection Control Services
  • Consulting and Training Services

Hospital-Acquired Infection (HAI) Control Market Market Segmented by Infection Control Practice:

• Hand Hygiene Management
  • Alcohol Based Hand Rubs
  • Hand Wash Solutions
• Surface Disinfection
  • High Touch Surface Cleaning
  • Floor and Environmental Cleaning
• Instrument Sterilization
  • Central Sterile Processing
  • Point of Use Sterilization
• Personal Protective Equipment Usage
  • Gloves and Gowns Usage
  • Masks and Respirators
• Environmental Monitoring
  • Air Quality Monitoring
  • Surface Contamination Testing

Hospital-Acquired Infection (HAI) Control Market Market Segmented by Technology:

• Sterilization Technology
  • Heat Sterilization
  • Low Temperature Sterilization
• Disinfection Technology
  • Chemical Disinfection
  • Ultraviolet Disinfection
  • Hydrogen Peroxide Vapor

Hospital-Acquired Infection (HAI) Control Market Market Segmented by Application:

• Surgical Site Infections
  • Pre Surgical Infection Prevention
  • Post Surgical Infection Control
• Bloodstream Infections
  • Catheter Related Infections
• Urinary Tract Infections
  • Catheter Associated UTIs
• Hospital Acquired Pneumonia
  • Ventilator Associated Pneumonia
• Gastrointestinal Infections
  • Clostridioides difficile Infection

Hospital-Acquired Infection (HAI) Control Market Market Segmented by End-user:

• Hospitals and Intensive Care Units
  • General Hospitals
  • Specialty Hospitals
• Ambulatory Surgical and Diagnostic Centers
  • Day Care Surgical Centers
• Other End Users
  • Long Term Care Facilities
  • Nursing Homes

Hospital-Acquired Infection (HAI) Control Market Market Segmented by Distribution Channel:

• Direct Sales to Healthcare Facilities
  • Long Term Supply Contracts
  • Group Purchasing Organizations
• Distributor Sales
  • Regional Distributors
  • National Distributors

Hospital-Acquired Infection (HAI) Control Market Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• USA Centers for Disease Control and Prevention. (2024). CDC National Healthcare Safety Network: HAI Surveillance Data. CDC.
• World Health Organization. (2025). WHO Guidelines on Core Components of Infection Prevention and Control. WHO.
• European Centre for Disease Prevention and Control. (2024). ECDC Healthcare-Associated Infections Surveillance Report. ECDC.
• Joint Commission International. (2024). JCI Accreditation Standards: Infection Prevention Requirements. JCI.
• Society for Healthcare Epidemiology of America. (2024). SHEA Clinical Practice Guidelines for HAI Prevention. SHEA.
• USA Food and Drug Administration. (2024). FDA Guidance on Hospital Disinfection and Sterilization Devices. FDA.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

• Estimating the size of the market and revenue from 2026 to 2036.
• Segmentation by Component, Infection Control Practice, Technology, Application, End-user, Distribution Channel, and region.
• Insights about more than 30 markets across regions.
• Technology and treatment landscape analysis.
• Assessment of the competitive landscape.
• Finding investment opportunities across segments and regions.
• Supply chain and distribution analysis.
• Delivery of data in PDF and Excel formats.